BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6494973)

  • 1. Heterogeneous acute leukemias.
    Brody JP; Krause JR; Kaplan SS; Penchansky L
    South Med J; 1984 Nov; 77(11):1461-4. PubMed ID: 6494973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal development, stem-cell differentiation, and clinical remissions in acute nonlymphocytic leukemia.
    Fialkow PJ; Singer JW; Raskind WH; Adamson JW; Jacobson RJ; Bernstein ID; Dow LW; Najfeld V; Veith R
    N Engl J Med; 1987 Aug; 317(8):468-73. PubMed ID: 3614291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple lineage reactivity in childhood leukemia.
    Penchansky L; Kaplan SS; Krause JR
    Pediatr Pathol; 1990; 10(1-2):217-29. PubMed ID: 2179918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Terminal deoxynucleotidyl transferase in acute leukemias by direct immunofluorescence.
    Nair CN; Gothoskar BP; Gladstone B; Badrinath Y; Chhajlani V; Karnik M; Nerurkar A; Damle SR; Redkar SL; Gopal R
    Neoplasma; 1987; 34(3):305-11. PubMed ID: 3302737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terminal deoxynucleotidyl transferase activity in childhood leukemia.
    Winick N; Steinherz PG; Miller DR
    Cancer; 1985 May; 55(9):1943-7. PubMed ID: 3978575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Philadelphia chromosome in acute leukemia.
    Bloomfield CD; Lindquist LL; Brunning RD; Yunis JJ; Coccia PF
    Virchows Arch B Cell Pathol; 1978 Nov; 29(1-2):81-91. PubMed ID: 103315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TdT+/nonlymphoid antigen+ acute leukemias: immunologic and karyotypic monitoring during therapy and at relapse suggests the transformation of a bipotential stem cell.
    Paietta E; Gucalp R; Papenhausen P; Dutcher JP; Wiernik PH
    Leukemia; 1989 Jul; 3(7):485-91. PubMed ID: 2733453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Philadelphia chromosome and terminal transferase-positive acute leukemia: similarity of terminal phase of chronic myelogenous leukemia and de novo acute presentation.
    Jain K; Arlin Z; Mertelsmann R; Gee T; Kempin S; Koziner B; Middleton A; Jhanwar S; Chaganti R; Clarkson B
    J Clin Oncol; 1983 Nov; 1(11):669-76. PubMed ID: 6366129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features and biological implications of acute mixed lineage (hybrid) leukemias.
    Altman AJ
    Am J Pediatr Hematol Oncol; 1990; 12(2):123-33. PubMed ID: 2198821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing "difficult" acute leukemias. A combined electron microscopic and immunological marker study.
    Hewson JW; Bradstock KF; Kerr A; Rose RG
    Pathology; 1986 Jan; 18(1):99-110. PubMed ID: 3014425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of initial terminal deoxynucleotidyl transferase determinations in childhood acute leukemias.
    Kalwinsky DK; Weatherred WH; Dahl GV; Bowman WP; Melvin SL; Coleman MS; Bollum FJ
    Cancer Res; 1981 Jul; 41(7):2877-81. PubMed ID: 7018672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiparameter analysis of acute mixed lineage leukemia: correlation of a B/myeloid immunophenotype and immunoglobulin and T-cell receptor gene rearrangements with the presence of the Philadelphia chromosome translocation in acute leukemias with myeloid morphology.
    Saikevych IA; Kerrigan DP; McConnell TS; Head DR; Appelbaum FR; Willman CL
    Leukemia; 1991 May; 5(5):373-82. PubMed ID: 2033959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the Technicon H-1 in the characterization of leukemias.
    Krause JR; Costello RT; Krause J; Penchansky L
    Arch Pathol Lab Med; 1988 Sep; 112(9):889-94. PubMed ID: 3166371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed phenotype acute leukemia with t(11;19)(q23;p13.3)/ MLL-MLLT1(ENL), B/T-lymphoid type: A first case report.
    Naghashpour M; Lancet J; Moscinski L; Zhang L
    Am J Hematol; 2010 Jun; 85(6):451-4. PubMed ID: 20513125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of leukemia cell terminal transferase measurements.
    McCaffrey R; Lillquist A; Sallan S; Cohen E; Osband M
    Cancer Res; 1981 Nov; 41(11 Pt 2):4814-20. PubMed ID: 7028251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical utility of terminal deoxynucleotidyl transferase and adenosine deaminase determinations in adult leukemia with a lymphoid phenotype.
    Brusamolino E; Isernia P; Lazzarino M; Scovassi I; Bertazzoni U; Bernasconi C
    J Clin Oncol; 1984 Aug; 2(8):871-80. PubMed ID: 6589363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic significance of terminal deoxynucleotidyl transferase (TDT) in patients with leukemias and malignant lymphomas.
    Mertelsmann R
    Adv Exp Med Biol; 1982; 145():259-77. PubMed ID: 7051779
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute leukemia presenting with myeloid and lymphoid cell markers.
    Scamurra DO; Davey FR; Nelson DA; Kurec AS; Goldberg J
    Ann Clin Lab Sci; 1983; 13(6):496-502. PubMed ID: 6197929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histochemical study of acute leukemia.
    Yam LT; Li CY; Wolfe HJ; Moy PW
    Arch Pathol; 1974 Mar; 97(3):129-35. PubMed ID: 4521339
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute nonlymphocytic leukemia with eosinophilic differentiation.
    Gabbas AG; Li CY
    Am J Hematol; 1986 Jan; 21(1):29-38. PubMed ID: 3706287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.